Radiochemistry facility for medical radioisotopes

The RECUMO project offers a structural solution for the radioactive residues that remain after the production of medical radioisotopes. The project makes use of the latest technology in terms of radiochemistry. The Belgian Nuclear Research Center SCK CEN and the National Institute for Radioelements (IRE) put the first spade into the ground for the RECUMO building in early 2023. From 2026 onwards, the facility will convert radioactive residues into pure, low-enriched uranium. This will give the residues a new lease on life. This includes fuel for research reactors or for the production of medical radioisotopes. As such, RECUMO is guaranteeing the global supply of medical radioisotopes. IRE and SCK CEN are together responsible for a quarter of their global production. The organisations have made a difference to millions of patients in the past 50 years. RECUMO will process both current residues and residues produced in the future, up to the year 2038.